US Stock MarketDetailed Quotes

VNDA Vanda Pharmaceuticals

Watchlist
  • 4.760
  • -0.160-3.25%
Trading Mar 21 15:56 ET
277.58MMarket Cap-14.42P/E (TTM)

Vanda Pharmaceuticals Key Stats

Vanda Pharmaceuticals Q4 2024 Earnings Date

Currency:USDFeb 13, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
52.25M
53.19M
+935.00K
Beat Est.
+15.42%
+17.48%
+1.79%
EPS
-0.11
-0.08
+0.03
Beat Est.
-175.44%
-100.00%
+27.21%
Buy

Feb 28, 2025

Vanda Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 45.134M--
May 3, 20232023/Q1-- / 62.500M--
Feb 13, 20252024/Q453.185M / 52.250M--
Nov 6, 20242024/Q347.651M / 49.155M--
Jul 31, 20242024/Q250.474M / 47.860M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 45.134M--
May 3, 20232023/Q1-- / 62.500M--
Feb 13, 20252024/Q453.185M / 52.250M--
Nov 6, 20242024/Q347.651M / 49.155M--
Jul 31, 20242024/Q250.474M / 47.860M--

Unlock Free Earnings Estimates

Vanda Pharmaceuticals Earnings Reports

Read more

Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 28, 2025

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data